User profiles for F. Dhermain

Frédéric Dhermain

Gustave Roussy University Hospital
Verified email at gustaveroussy.fr
Cited by 6762

European Association for Neuro-Oncology (EANO) guideline on the diagnosis and treatment of adult astrocytic and oligodendroglial gliomas

…, M Bendszus, JC Reijneveld, F Dhermain… - The lancet …, 2017 - thelancet.com
The European Association for Neuro-Oncology guideline provides recommendations for the
clinical care of adult patients with astrocytic and oligodendroglial gliomas, including …

Advanced MRI and PET imaging for assessment of treatment response in patients with gliomas

FG Dhermain, P Hau, H Lanfermann… - The Lancet …, 2010 - thelancet.com
… 18 F-FDG, 11 C-methionine, 18 F-FET, and 18 F-FLT are … F-FDG), aminoacids ( 11 C-methionine
or 18 F-FET) or nucleosides ( 18 F-FLT), and increased expression of hexokinase ( 18 F-…

PET imaging in patients with meningioma—report of the RANO/PET Group

…, MA Vogelbaum, G Zadeh, F Dhermain… - Neuro …, 2017 - academic.oup.com
… In neuro-oncology, particularly cerebral gliomas have been extensively studied using initially
18 F-2-fluoro-2-deoxy-D-glucose ( 18 F-FDG) and more recently amino acid PET tracers. In …

Temozolomide chemotherapy versus radiotherapy in high-risk low-grade glioma (EORTC 22033-26033): a randomised, open-label, phase 3 intergroup study

…, R Enting, M Reni, B Thiessen, F Dhermain… - The Lancet …, 2016 - thelancet.com
Background Outcome of low-grade glioma (WHO grade II) is highly variable, reflecting
molecular heterogeneity of the disease. We compared two different, single-modality treatment …

Interim results from the CATNON trial (EORTC study 26053-22054) of treatment with concurrent and adjuvant temozolomide for 1p/19q non-co-deleted anaplastic …

…, S Pascoe, U Herrlinger, P Hau, F Dhermain… - The Lancet, 2017 - thelancet.com
Background The role of temozolomide chemotherapy in newly diagnosed 1p/19q non-co-deleted
anaplastic gliomas, which are associated with lower sensitivity to chemotherapy and …

Adjuvant and concurrent temozolomide for 1p/19q non-co-deleted anaplastic glioma (CATNON; EORTC study 26053-22054): second interim analysis of a randomised …

…, E Lim, U Herrlinger, P Hau, F Dhermain… - The Lancet …, 2021 - thelancet.com
Background The CATNON trial investigated the addition of concurrent, adjuvant, and both
current and adjuvant temozolomide to radiotherapy in adults with newly diagnosed 1p/19q non…

Chordomas of the base of the skull and upper cervical spine. One hundred patients irradiated by a 3D conformal technique combining photon and proton beams

G Noël, L Feuvret, V Calugaru, F Dhermain… - Acta …, 2005 - Taylor & Francis
To define the prognostic factors for local control and overall survival among 100 consecutive
patients with chordoma of the base of skull or upper cervical spine treated by fractionated …

Standardization of brain MR images across machines and protocols: bridging the gap for MRI-based radiomics

…, E Battistella, M Vakalopoulou, F Dhermain… - Scientific reports, 2020 - nature.com
Radiomics relies on the extraction of a wide variety of quantitative image-based features to
provide decision support. Magnetic resonance imaging (MRI) contributes to the …

Evaluation of an atlas-based automatic segmentation software for the delineation of brain organs at risk in a radiation therapy clinical context

A Isambert, F Dhermain, F Bidault… - Radiotherapy and …, 2008 - Elsevier
BACKGROUND AND PURPOSE: Conformal radiation therapy techniques require the delineation
of volumes of interest, a time-consuming and operator-dependent task. In this work, we …

Radiotherapy of high-grade gliomas: current standards and new concepts, innovations in imaging and radiotherapy, and new therapeutic approaches

F Dhermain - Chinese journal of cancer, 2014 - pmc.ncbi.nlm.nih.gov
… Biopsy validation of PET with another amino acid tracer, 18 F-dopamine (DOPA), and its
biodistribution in gliomas for radiation target delineation were recently published in a series of …